Acta Neuropathologica Communications

Top Research Topics at Acta neuropathologica communications?

The discussions in Acta neuropathologica communications mainly cover the fields of Pathology, Neuroscience, Neurology, Cell biology and Neurodegeneration. The research on Pathology featured in Acta neuropathologica communications combines topics in other fields like White matter and Genetically modified mouse. The field of Transgene is the anchor for the Genetically modified mouse studies presented in it.

The studies on Neuroscience discussed can also contribute to research in the domains of Alpha-synuclein and Tauopathy. The studies in Neurology featured incorporate elements of Internal medicine, Dementia and Disease. The study on Cell biology presented in it intersects with subjects under the field of Amyotrophic lateral sclerosis.

While the journal focused on Neurodegeneration, it was also able to explore topics like Neuroinflammation, Tau protein, Microglia and Parkinson's disease. Research in Microglia tackled falls within the umbrella of Immunology.

• Pathology (37.22%)
• Neuroscience (19.19%)
• Neurology (18.96%)

What are the most cited papers published in the journal?

• Induction of a common microglia gene expression signature by aging and neurodegenerative conditions: a co-expression meta-analysis (314 citations)
• An autoradiographic evaluation of AV-1451 Tau PET in dementia. (298 citations)
• Inconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer's disease. (282 citations)

Research areas of the most cited articles at Acta neuropathologica communications:

The most cited publications focus largely on the fields of Pathology, Neuroscience, Neurodegeneration, Neurology and Microglia. The most cited papers explore issues in Pathology which can be linked to other research areas like Cerebral cortex and Internal medicine. The study of Neuroscience in the published papers encompasses disciplines such as Alpha-synuclein, as well as fields such as Substantia nigra, Cell biology, Dementia with Lewy bodies and Genetically modified mouse, all of which overlap with one another.

What topics the last edition of the journal is best known for?

• Gene
• Internal medicine
• Cancer

The previous edition focused in particular on these issues:

Acta neuropathologica communications explores disciplines such as Pathology, Neurology, Cell biology, Neurodegeneration and Neuroscience. The close relationship between Genetically modified mouse and Antibody is one of the points of interest dissected in Pathology research. The research on Neurology tackled can also make contributions to studies in the areas of Frontotemporal lobar degeneration, Pathological, Disease and Traumatic brain injury.

Topics in Cell biology were tackled in line with various other fields like Autophagy, Amyotrophic lateral sclerosis, Motor neuron, Ribosome and Amyloid. The overlapping concepts between Neuroinflammation and Microglia, Neuroprotection, Pathogenesis and Gliosis are the key highlights of Neurodegeneration study. Neuroscience research is concerned with Hippocampus in particular.

The most cited articles from the last journal are:

• Microglial gene signature reveals loss of homeostatic microglia associated with neurodegeneration of Alzheimer's disease. (24 citations)
• Trans-synaptic spreading of alpha-synuclein pathology through sensory afferents leads to sensory nerve degeneration and neuropathic pain. (15 citations)
• Frequent SLC35A2 brain mosaicism in mild malformation of cortical development with oligodendroglial hyperplasia in epilepsy (MOGHE) (11 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Acta neuropathologica communications (based on the number of publications) are:

• John Q. Trojanowski (29 papers) published 7 papers at the last edition, 6 more than at the previous edition,
• Dennis W. Dickson (22 papers) published 3 papers at the last edition, 6 less than at the previous edition,
• Virginia M.-Y. Lee (19 papers) published 2 papers at the last edition,
• Luc Buée (15 papers) published 2 papers at the last edition, 1 more than at the previous edition,
• Glenda M. Halliday (14 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Acta neuropathologica communications (based on the number of publications) are:

• French Institute of Health and Medical Research (48 papers) published 4 papers at the last edition, 6 less than at the previous edition,
• Mayo Clinic (48 papers) published 6 papers at the last edition, 6 less than at the previous edition,
• University of Pennsylvania (44 papers) published 8 papers at the last edition, 2 more than at the previous edition,
• Harvard University (44 papers) published 5 papers at the last edition, 5 less than at the previous edition,
• University of California, San Francisco (43 papers) published 4 papers at the last edition, 4 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 1.18% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 21.43% were posted by at least one author from the top 10 institutions publishing in the journal. Another 17.86% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 21.43% of all publications and 39.29% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Potential Career Paths in Neuropathology

After gaining considerable knowledge and experience in the field of neuropathology and related disciplines through relevant research and study, individuals may wish to translate their expertise into a rewarding career. One of the potential career paths in this domain is becoming a speech therapist, specifically in the realm of neurological disorders.

Speech therapists, or Speech-Language Pathologists, work closely with patients who have speech and communication disorders, often resulting from neurological conditions. They play a vital role in the treatment of patients suffering from stroke, traumatic brain injury, and degenerative diseases like Parkinson's and ALS (Amyotrophic lateral sclerosis). They devise and implement effective treatment plans to help patients regain or improve their speech and communication abilities.

If you find the intersection of neuropathology and speech therapy engaging and wish to venture into this field, you can explore our detailed guide on how to become a speech therapist in Georgia. This guide provides comprehensive step-by-step instructions, from selecting the right educational program to successfully navigating the licencing process within the state of Georgia.

Remember, choosing a career is about aligning your passion, skills and academic progress. Make an informed decision for a rewarding journey in the field of Neuropathology.